The Male Infertility Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Male Infertility Treatment market size is estimated to be worth US$ 1341.5 million in 2021 and is forecast to a readjusted size of USD 2234.4 million by 2028 with a CAGR of 7.6% during review period. Hospitals accounting for % of the Male Infertility Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While DNA Fragmentation Technique segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Male Infertility Treatment include Merck Serono, Aytu BioScience, Bayer, Cadila, and Intas Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Male Infertility Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DNA Fragmentation Technique
Oxidative Stress Analysis
Microscopic Examination
Sperm Agglutination
Computer Assisted Semen Analysis
Sperm Penetration Assay
Market segment by Application, can be divided into
Hospitals
Clinics
Others
Market segment by players, this report covers
Merck Serono
Aytu BioScience
Bayer
Cadila
Intas Pharma
Halotech DNA
SCSA diagnostics
Andrology Solutions
Livzon Pharmaceutical Group Inc.
Zhejiang Xianju Pharmaceutical Co.,Ltd.
GeneScience Pharmaceuticals Co., Ltd.
Abeona Therapeutics Inc.
ASKA Pharmaceutical Co., Ltd.
Bristol Myers Squibb
Church & Dwight
Intas Biopharmaceuticals
Eli Lilly and Company
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Male Infertility Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Male Infertility Treatment, with revenue, gross margin and global market share of Male Infertility Treatment from 2019 to 2022.
Chapter 3, the Male Infertility Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Male Infertility Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Male Infertility Treatment research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Male Infertility Treatment
1.2 Classification of Male Infertility Treatment by Type
1.2.1 Overview: Global Male Infertility Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Male Infertility Treatment Revenue Market Share by Type in 2021
1.2.3 DNA Fragmentation Technique
1.2.4 Oxidative Stress Analysis
1.2.5 Microscopic Examination
1.2.6 Sperm Agglutination
1.2.7 Computer Assisted Semen Analysis
1.2.8 Sperm Penetration Assay
1.3 Global Male Infertility Treatment Market by Application
1.3.1 Overview: Global Male Infertility Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Male Infertility Treatment Market Size & Forecast
1.5 Global Male Infertility Treatment Market Size and Forecast by Region
1.5.1 Global Male Infertility Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Male Infertility Treatment Market Size by Region, (2017-2022)
1.5.3 North America Male Infertility Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Male Infertility Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Male Infertility Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Male Infertility Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Male Infertility Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Male Infertility Treatment Market Drivers
1.6.2 Male Infertility Treatment Market Restraints
1.6.3 Male Infertility Treatment Trends Analysis
2 Company Profiles
2.1 Merck Serono
2.1.1 Merck Serono Details
2.1.2 Merck Serono Major Business
2.1.3 Merck Serono Male Infertility Treatment Product and Solutions
2.1.4 Merck Serono Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Merck Serono Recent Developments and Future Plans
2.2 Aytu BioScience
2.2.1 Aytu BioScience Details
2.2.2 Aytu BioScience Major Business
2.2.3 Aytu BioScience Male Infertility Treatment Product and Solutions
2.2.4 Aytu BioScience Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Aytu BioScience Recent Developments and Future Plans
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Male Infertility Treatment Product and Solutions
2.3.4 Bayer Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bayer Recent Developments and Future Plans
2.4 Cadila
2.4.1 Cadila Details
2.4.2 Cadila Major Business
2.4.3 Cadila Male Infertility Treatment Product and Solutions
2.4.4 Cadila Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Cadila Recent Developments and Future Plans
2.5 Intas Pharma
2.5.1 Intas Pharma Details
2.5.2 Intas Pharma Major Business
2.5.3 Intas Pharma Male Infertility Treatment Product and Solutions
2.5.4 Intas Pharma Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Intas Pharma Recent Developments and Future Plans
2.6 Halotech DNA
2.6.1 Halotech DNA Details
2.6.2 Halotech DNA Major Business
2.6.3 Halotech DNA Male Infertility Treatment Product and Solutions
2.6.4 Halotech DNA Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Halotech DNA Recent Developments and Future Plans
2.7 SCSA diagnostics
2.7.1 SCSA diagnostics Details
2.7.2 SCSA diagnostics Major Business
2.7.3 SCSA diagnostics Male Infertility Treatment Product and Solutions
2.7.4 SCSA diagnostics Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 SCSA diagnostics Recent Developments and Future Plans
2.8 Andrology Solutions
2.8.1 Andrology Solutions Details
2.8.2 Andrology Solutions Major Business
2.8.3 Andrology Solutions Male Infertility Treatment Product and Solutions
2.8.4 Andrology Solutions Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Andrology Solutions Recent Developments and Future Plans
2.9 Livzon Pharmaceutical Group Inc.
2.9.1 Livzon Pharmaceutical Group Inc. Details
2.9.2 Livzon Pharmaceutical Group Inc. Major Business
2.9.3 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Product and Solutions
2.9.4 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Livzon Pharmaceutical Group Inc. Recent Developments and Future Plans
2.10 Zhejiang Xianju Pharmaceutical Co.,Ltd.
2.10.1 Zhejiang Xianju Pharmaceutical Co.,Ltd. Details
2.10.2 Zhejiang Xianju Pharmaceutical Co.,Ltd. Major Business
2.10.3 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Product and Solutions
2.10.4 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Developments and Future Plans
2.11 GeneScience Pharmaceuticals Co., Ltd.
2.11.1 GeneScience Pharmaceuticals Co., Ltd. Details
2.11.2 GeneScience Pharmaceuticals Co., Ltd. Major Business
2.11.3 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Product and Solutions
2.11.4 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 GeneScience Pharmaceuticals Co., Ltd. Recent Developments and Future Plans
2.12 Abeona Therapeutics Inc.
2.12.1 Abeona Therapeutics Inc. Details
2.12.2 Abeona Therapeutics Inc. Major Business
2.12.3 Abeona Therapeutics Inc. Male Infertility Treatment Product and Solutions
2.12.4 Abeona Therapeutics Inc. Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Abeona Therapeutics Inc. Recent Developments and Future Plans
2.13 ASKA Pharmaceutical Co., Ltd.
2.13.1 ASKA Pharmaceutical Co., Ltd. Details
2.13.2 ASKA Pharmaceutical Co., Ltd. Major Business
2.13.3 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Product and Solutions
2.13.4 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 ASKA Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.14 Bristol Myers Squibb
2.14.1 Bristol Myers Squibb Details
2.14.2 Bristol Myers Squibb Major Business
2.14.3 Bristol Myers Squibb Male Infertility Treatment Product and Solutions
2.14.4 Bristol Myers Squibb Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Bristol Myers Squibb Recent Developments and Future Plans
2.15 Church & Dwight
2.15.1 Church & Dwight Details
2.15.2 Church & Dwight Major Business
2.15.3 Church & Dwight Male Infertility Treatment Product and Solutions
2.15.4 Church & Dwight Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Church & Dwight Recent Developments and Future Plans
2.16 Intas Biopharmaceuticals
2.16.1 Intas Biopharmaceuticals Details
2.16.2 Intas Biopharmaceuticals Major Business
2.16.3 Intas Biopharmaceuticals Male Infertility Treatment Product and Solutions
2.16.4 Intas Biopharmaceuticals Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Intas Biopharmaceuticals Recent Developments and Future Plans
2.17 Eli Lilly and Company
2.17.1 Eli Lilly and Company Details
2.17.2 Eli Lilly and Company Major Business
2.17.3 Eli Lilly and Company Male Infertility Treatment Product and Solutions
2.17.4 Eli Lilly and Company Male Infertility Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Eli Lilly and Company Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Male Infertility Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Male Infertility Treatment Players Market Share in 2021
3.2.2 Top 10 Male Infertility Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Male Infertility Treatment Players Head Office, Products and Services Provided
3.4 Male Infertility Treatment Mergers & Acquisitions
3.5 Male Infertility Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Male Infertility Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Male Infertility Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Male Infertility Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Male Infertility Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Male Infertility Treatment Revenue by Type (2017-2028)
6.2 North America Male Infertility Treatment Revenue by Application (2017-2028)
6.3 North America Male Infertility Treatment Market Size by Country
6.3.1 North America Male Infertility Treatment Revenue by Country (2017-2028)
6.3.2 United States Male Infertility Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Male Infertility Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Male Infertility Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Male Infertility Treatment Revenue by Type (2017-2028)
7.2 Europe Male Infertility Treatment Revenue by Application (2017-2028)
7.3 Europe Male Infertility Treatment Market Size by Country
7.3.1 Europe Male Infertility Treatment Revenue by Country (2017-2028)
7.3.2 Germany Male Infertility Treatment Market Size and Forecast (2017-2028)
7.3.3 France Male Infertility Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Male Infertility Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Male Infertility Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Male Infertility Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Male Infertility Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Male Infertility Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Male Infertility Treatment Market Size by Region
8.3.1 Asia-Pacific Male Infertility Treatment Revenue by Region (2017-2028)
8.3.2 China Male Infertility Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Male Infertility Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Male Infertility Treatment Market Size and Forecast (2017-2028)
8.3.5 India Male Infertility Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Male Infertility Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Male Infertility Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Male Infertility Treatment Revenue by Type (2017-2028)
9.2 South America Male Infertility Treatment Revenue by Application (2017-2028)
9.3 South America Male Infertility Treatment Market Size by Country
9.3.1 South America Male Infertility Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Male Infertility Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Male Infertility Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Male Infertility Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Male Infertility Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Male Infertility Treatment Market Size by Country
10.3.1 Middle East & Africa Male Infertility Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Male Infertility Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Male Infertility Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Male Infertility Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Male Infertility Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Male Infertility Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Male Infertility Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Male Infertility Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Male Infertility Treatment Revenue Market Share by Region (2023-2028)
Table 6. Merck Serono Corporate Information, Head Office, and Major Competitors
Table 7. Merck Serono Major Business
Table 8. Merck Serono Male Infertility Treatment Product and Solutions
Table 9. Merck Serono Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Aytu BioScience Corporate Information, Head Office, and Major Competitors
Table 11. Aytu BioScience Major Business
Table 12. Aytu BioScience Male Infertility Treatment Product and Solutions
Table 13. Aytu BioScience Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bayer Corporate Information, Head Office, and Major Competitors
Table 15. Bayer Major Business
Table 16. Bayer Male Infertility Treatment Product and Solutions
Table 17. Bayer Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Cadila Corporate Information, Head Office, and Major Competitors
Table 19. Cadila Major Business
Table 20. Cadila Male Infertility Treatment Product and Solutions
Table 21. Cadila Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Intas Pharma Corporate Information, Head Office, and Major Competitors
Table 23. Intas Pharma Major Business
Table 24. Intas Pharma Male Infertility Treatment Product and Solutions
Table 25. Intas Pharma Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Halotech DNA Corporate Information, Head Office, and Major Competitors
Table 27. Halotech DNA Major Business
Table 28. Halotech DNA Male Infertility Treatment Product and Solutions
Table 29. Halotech DNA Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. SCSA diagnostics Corporate Information, Head Office, and Major Competitors
Table 31. SCSA diagnostics Major Business
Table 32. SCSA diagnostics Male Infertility Treatment Product and Solutions
Table 33. SCSA diagnostics Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Andrology Solutions Corporate Information, Head Office, and Major Competitors
Table 35. Andrology Solutions Major Business
Table 36. Andrology Solutions Male Infertility Treatment Product and Solutions
Table 37. Andrology Solutions Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Livzon Pharmaceutical Group Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Livzon Pharmaceutical Group Inc. Major Business
Table 40. Livzon Pharmaceutical Group Inc. Male Infertility Treatment Product and Solutions
Table 41. Livzon Pharmaceutical Group Inc. Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Zhejiang Xianju Pharmaceutical Co.,Ltd. Corporate Information, Head Office, and Major Competitors
Table 43. Zhejiang Xianju Pharmaceutical Co.,Ltd. Major Business
Table 44. Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Product and Solutions
Table 45. Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. GeneScience Pharmaceuticals Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 47. GeneScience Pharmaceuticals Co., Ltd. Major Business
Table 48. GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Product and Solutions
Table 49. GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Abeona Therapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Abeona Therapeutics Inc. Major Business
Table 52. Abeona Therapeutics Inc. Male Infertility Treatment Product and Solutions
Table 53. Abeona Therapeutics Inc. Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. ASKA Pharmaceutical Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 55. ASKA Pharmaceutical Co., Ltd. Major Business
Table 56. ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Product and Solutions
Table 57. ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Bristol Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 59. Bristol Myers Squibb Major Business
Table 60. Bristol Myers Squibb Male Infertility Treatment Product and Solutions
Table 61. Bristol Myers Squibb Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Church & Dwight Corporate Information, Head Office, and Major Competitors
Table 63. Church & Dwight Major Business
Table 64. Church & Dwight Male Infertility Treatment Product and Solutions
Table 65. Church & Dwight Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Intas Biopharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 67. Intas Biopharmaceuticals Major Business
Table 68. Intas Biopharmaceuticals Male Infertility Treatment Product and Solutions
Table 69. Intas Biopharmaceuticals Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 71. Eli Lilly and Company Major Business
Table 72. Eli Lilly and Company Male Infertility Treatment Product and Solutions
Table 73. Eli Lilly and Company Male Infertility Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Global Male Infertility Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 75. Global Male Infertility Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 76. Breakdown of Male Infertility Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Male Infertility Treatment Players Head Office, Products and Services Provided
Table 78. Male Infertility Treatment Mergers & Acquisitions in the Past Five Years
Table 79. Male Infertility Treatment New Entrants and Expansion Plans
Table 80. Global Male Infertility Treatment Revenue (USD Million) by Type (2017-2022)
Table 81. Global Male Infertility Treatment Revenue Share by Type (2017-2022)
Table 82. Global Male Infertility Treatment Revenue Forecast by Type (2023-2028)
Table 83. Global Male Infertility Treatment Revenue by Application (2017-2022)
Table 84. Global Male Infertility Treatment Revenue Forecast by Application (2023-2028)
Table 85. North America Male Infertility Treatment Revenue by Type (2017-2022) & (USD Million)
Table 86. North America Male Infertility Treatment Revenue by Type (2023-2028) & (USD Million)
Table 87. North America Male Infertility Treatment Revenue by Application (2017-2022) & (USD Million)
Table 88. North America Male Infertility Treatment Revenue by Application (2023-2028) & (USD Million)
Table 89. North America Male Infertility Treatment Revenue by Country (2017-2022) & (USD Million)
Table 90. North America Male Infertility Treatment Revenue by Country (2023-2028) & (USD Million)
Table 91. Europe Male Infertility Treatment Revenue by Type (2017-2022) & (USD Million)
Table 92. Europe Male Infertility Treatment Revenue by Type (2023-2028) & (USD Million)
Table 93. Europe Male Infertility Treatment Revenue by Application (2017-2022) & (USD Million)
Table 94. Europe Male Infertility Treatment Revenue by Application (2023-2028) & (USD Million)
Table 95. Europe Male Infertility Treatment Revenue by Country (2017-2022) & (USD Million)
Table 96. Europe Male Infertility Treatment Revenue by Country (2023-2028) & (USD Million)
Table 97. Asia-Pacific Male Infertility Treatment Revenue by Type (2017-2022) & (USD Million)
Table 98. Asia-Pacific Male Infertility Treatment Revenue by Type (2023-2028) & (USD Million)
Table 99. Asia-Pacific Male Infertility Treatment Revenue by Application (2017-2022) & (USD Million)
Table 100. Asia-Pacific Male Infertility Treatment Revenue by Application (2023-2028) & (USD Million)
Table 101. Asia-Pacific Male Infertility Treatment Revenue by Region (2017-2022) & (USD Million)
Table 102. Asia-Pacific Male Infertility Treatment Revenue by Region (2023-2028) & (USD Million)
Table 103. South America Male Infertility Treatment Revenue by Type (2017-2022) & (USD Million)
Table 104. South America Male Infertility Treatment Revenue by Type (2023-2028) & (USD Million)
Table 105. South America Male Infertility Treatment Revenue by Application (2017-2022) & (USD Million)
Table 106. South America Male Infertility Treatment Revenue by Application (2023-2028) & (USD Million)
Table 107. South America Male Infertility Treatment Revenue by Country (2017-2022) & (USD Million)
Table 108. South America Male Infertility Treatment Revenue by Country (2023-2028) & (USD Million)
Table 109. Middle East & Africa Male Infertility Treatment Revenue by Type (2017-2022) & (USD Million)
Table 110. Middle East & Africa Male Infertility Treatment Revenue by Type (2023-2028) & (USD Million)
Table 111. Middle East & Africa Male Infertility Treatment Revenue by Application (2017-2022) & (USD Million)
Table 112. Middle East & Africa Male Infertility Treatment Revenue by Application (2023-2028) & (USD Million)
Table 113. Middle East & Africa Male Infertility Treatment Revenue by Country (2017-2022) & (USD Million)
Table 114. Middle East & Africa Male Infertility Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Male Infertility Treatment Picture
Figure 2. Global Male Infertility Treatment Revenue Market Share by Type in 2021
Figure 3. DNA Fragmentation Technique
Figure 4. Oxidative Stress Analysis
Figure 5. Microscopic Examination
Figure 6. Sperm Agglutination
Figure 7. Computer Assisted Semen Analysis
Figure 8. Sperm Penetration Assay
Figure 9. Male Infertility Treatment Revenue Market Share by Application in 2021
Figure 10. Hospitals Picture
Figure 11. Clinics Picture
Figure 12. Others Picture
Figure 13. Global Male Infertility Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Male Infertility Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Male Infertility Treatment Revenue Market Share by Region (2017-2028)
Figure 16. Global Male Infertility Treatment Revenue Market Share by Region in 2021
Figure 17. North America Male Infertility Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Male Infertility Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Male Infertility Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Male Infertility Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Male Infertility Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Male Infertility Treatment Market Drivers
Figure 23. Male Infertility Treatment Market Restraints
Figure 24. Male Infertility Treatment Market Trends
Figure 25. Merck Serono Recent Developments and Future Plans
Figure 26. Aytu BioScience Recent Developments and Future Plans
Figure 27. Bayer Recent Developments and Future Plans
Figure 28. Cadila Recent Developments and Future Plans
Figure 29. Intas Pharma Recent Developments and Future Plans
Figure 30. Halotech DNA Recent Developments and Future Plans
Figure 31. SCSA diagnostics Recent Developments and Future Plans
Figure 32. Andrology Solutions Recent Developments and Future Plans
Figure 33. Livzon Pharmaceutical Group Inc. Recent Developments and Future Plans
Figure 34. Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Developments and Future Plans
Figure 35. GeneScience Pharmaceuticals Co., Ltd. Recent Developments and Future Plans
Figure 36. Abeona Therapeutics Inc. Recent Developments and Future Plans
Figure 37. ASKA Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Figure 38. Bristol Myers Squibb Recent Developments and Future Plans
Figure 39. Church & Dwight Recent Developments and Future Plans
Figure 40. Intas Biopharmaceuticals Recent Developments and Future Plans
Figure 41. Eli Lilly and Company Recent Developments and Future Plans
Figure 42. Global Male Infertility Treatment Revenue Share by Players in 2021
Figure 43. Male Infertility Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 44. Global Top 3 Players Male Infertility Treatment Revenue Market Share in 2021
Figure 45. Global Top 10 Players Male Infertility Treatment Revenue Market Share in 2021
Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 47. Global Male Infertility Treatment Revenue Share by Type in 2021
Figure 48. Global Male Infertility Treatment Market Share Forecast by Type (2023-2028)
Figure 49. Global Male Infertility Treatment Revenue Share by Application in 2021
Figure 50. Global Male Infertility Treatment Market Share Forecast by Application (2023-2028)
Figure 51. North America Male Infertility Treatment Sales Market Share by Type (2017-2028)
Figure 52. North America Male Infertility Treatment Sales Market Share by Application (2017-2028)
Figure 53. North America Male Infertility Treatment Revenue Market Share by Country (2017-2028)
Figure 54. United States Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Canada Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Mexico Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Europe Male Infertility Treatment Sales Market Share by Type (2017-2028)
Figure 58. Europe Male Infertility Treatment Sales Market Share by Application (2017-2028)
Figure 59. Europe Male Infertility Treatment Revenue Market Share by Country (2017-2028)
Figure 60. Germany Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. France Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. United Kingdom Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Russia Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Italy Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Asia-Pacific Male Infertility Treatment Sales Market Share by Type (2017-2028)
Figure 66. Asia-Pacific Male Infertility Treatment Sales Market Share by Application (2017-2028)
Figure 67. Asia-Pacific Male Infertility Treatment Revenue Market Share by Region (2017-2028)
Figure 68. China Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Japan Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South Korea Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. India Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Southeast Asia Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Australia Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South America Male Infertility Treatment Sales Market Share by Type (2017-2028)
Figure 75. South America Male Infertility Treatment Sales Market Share by Application (2017-2028)
Figure 76. South America Male Infertility Treatment Revenue Market Share by Country (2017-2028)
Figure 77. Brazil Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Argentina Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Middle East and Africa Male Infertility Treatment Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Male Infertility Treatment Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Male Infertility Treatment Revenue Market Share by Country (2017-2028)
Figure 82. Turkey Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Saudi Arabia Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. UAE Male Infertility Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Methodology
Figure 86. Research Process and Data Source